Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
17.52
+0.66 (3.91%)
At close: Aug 13, 2025, 4:00 PM
17.57
+0.05 (0.29%)
After-hours: Aug 13, 2025, 6:43 PM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $1.72 billion as of August 13, 2025. Its market cap has decreased by -34.16% in one year.
Market Cap
1.72B
Enterprise Value
736.10M
1-Year Change
-34.16%
Ranking
Category
Stock Price
$17.52
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $1.72B, an increase of 424.98%. That is a compound annual growth rate of 35.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 1.66B | -16.06% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | 4.61B | 1,305.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |